- Home
- LYV vs ONC Comparison
LYV vs ONC Comparison
Compare LYV & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYV
- ONC
- Stock Information
- Founded
- LYV 2005
- ONC 2010
- Country
- LYV United States
- ONC Switzerland
- Employees
- LYV N/A
- ONC N/A
- Industry
- LYV Services-Misc. Amusement & Recreation
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- LYV Consumer Discretionary
- ONC Health Care
- Exchange
- LYV Nasdaq
- ONC Nasdaq
- Market Cap
- LYV 35.0B
- ONC 31.5B
- IPO Year
- LYV N/A
- ONC N/A
- Fundamental
- Price
- LYV $153.10
- ONC $288.18
- Analyst Decision
- LYV Strong Buy
- ONC Strong Buy
- Analyst Count
- LYV 19
- ONC 9
- Target Price
- LYV $163.79
- ONC $335.78
- AVG Volume (30 Days)
- LYV 2.1M
- ONC 465.2K
- Earning Date
- LYV 08-07-2025
- ONC 08-06-2025
- Dividend Yield
- LYV N/A
- ONC N/A
- EPS Growth
- LYV 115.15
- ONC N/A
- EPS
- LYV 2.34
- ONC N/A
- Revenue
- LYV $23,721,438,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- LYV $13.04
- ONC $865.19
- Revenue Next Year
- LYV $8.92
- ONC $21.12
- P/E Ratio
- LYV $65.32
- ONC N/A
- Revenue Growth
- LYV N/A
- ONC 47.33
- 52 Week Low
- LYV $89.69
- ONC $170.99
- 52 Week High
- LYV $157.75
- ONC $313.29
- Technical
- Relative Strength Index (RSI)
- LYV 57.39
- ONC N/A
- Support Level
- LYV $143.25
- ONC N/A
- Resistance Level
- LYV $151.65
- ONC N/A
- Average True Range (ATR)
- LYV 4.14
- ONC 0.00
- MACD
- LYV -0.22
- ONC 0.00
- Stochastic Oscillator
- LYV 73.51
- ONC 0.00
About LYV Live Nation Entertainment Inc.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 45 countries, Live Nation promotes concerts globally and it owns, operates, or had exclusive booking rights to nearly 400 venues worldwide at the end of 2024, which the firm says makes it the second-largest operator of music venues globally. In 2024, Live Nation promoted nearly 55,000 events, drawing more than 150 million fans. Ticketmaster is a dominant global ticketing service, selling almost 640 million tickets in 2024.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.